Chronic renal failure, cachexia, and ghrelin.

作者: A. Laviano , Z. Krznaric , K. Sanchez-Lara , I. Preziosa , A. Cascino

DOI: 10.1155/2010/648045

关键词:

摘要: Protein energy wasting is frequently observed in patients with advanced chronic renal failure and end-stage disease. Anorexia reduced food intake are critical contributing factors negatively impact on patients' survival. Ghrelin a prophagic peptide produced by the stomach acting at hypothalamic level to increase activity of orexigenic neurons. In disease, plasma levels increased as likely effect clearance. Nevertheless, significantly reduced, suggesting inflammation-mediated resistance nuclei peripheral signals. A number forms evidence show that ghrelin could be overcome administration exogenous ghrelin. Therefore, has been proposed potential strategy improve protein wasting. Preliminary data encouraging although larger prospective clinical trials needed confirm results identify those who benefit most from

参考文章(42)
Sulaiman Sheriff, Rashika Joshi, Lou Ann Friend, J. Howard James, Ambikaipakan Balasubramaniam, Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Peptides. ,vol. 30, pp. 1909- 1913 ,(2009) , 10.1016/J.PEPTIDES.2009.06.029
Rocco Barazzoni, Michela Zanetti, Manuela Stulle, Maria Pia Mucci, Alessia Pirulli, Franca Dore, Giovanni Panzetta, Alfonso Vasile, Gianni Biolo, Gianfranco Guarnieri, Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. Clinical Nutrition. ,vol. 27, pp. 142- 149 ,(2008) , 10.1016/J.CLNU.2007.06.013
William E. Mitch, Proteolytic Mechanisms, Not Malnutrition, Cause Loss of Muscle Mass in Kidney Failure Journal of Renal Nutrition. ,vol. 16, pp. 208- 211 ,(2006) , 10.1053/J.JRN.2006.04.014
Roger D Cone, Anatomy and regulation of the central melanocortin system. Nature Neuroscience. ,vol. 8, pp. 571- 578 ,(2005) , 10.1038/NN1455
Christian S. Shinaberger, Ryan D. Kilpatrick, Deborah L. Regidor, Charles J. McAllister, Sander Greenland, Joel D. Kopple, Kamyar Kalantar-Zadeh, Longitudinal Associations Between Dietary Protein Intake and Survival in Hemodialysis Patients American Journal of Kidney Diseases. ,vol. 48, pp. 37- 49 ,(2006) , 10.1053/J.AJKD.2006.03.049
Kirsten L. Johansen, Anabolic and Catabolic Mechanisms in End-Stage Renal Disease Advances in Chronic Kidney Disease. ,vol. 16, pp. 501- 510 ,(2009) , 10.1053/J.ACKD.2009.07.007
William J. Evans, John E. Morley, Josep Argilés, Connie Bales, Vickie Baracos, Denis Guttridge, Aminah Jatoi, Kamyar Kalantar-Zadeh, Herbert Lochs, Giovanni Mantovani, Daniel Marks, William E. Mitch, Maurizio Muscaritoli, Armine Najand, Piotr Ponikowski, Filippo Rossi Fanelli, Morrie Schambelan, Annemie Schols, Michael Schuster, David Thomas, Robert Wolfe, Stefan D. Anker, Cachexia: a new definition. Clinical Nutrition. ,vol. 27, pp. 793- 799 ,(2008) , 10.1016/J.CLNU.2008.06.013
Akio Inui, Ghrelin: An orexigenic and somatotrophic signal from the stomach Nature Reviews Neuroscience. ,vol. 2, pp. 551- 560 ,(2001) , 10.1038/35086018
Miguel López, Ricardo Lage, Asish K. Saha, Diego Pérez-Tilve, María J. Vázquez, Luis Varela, Susana Sangiao-Alvarellos, Sulay Tovar, Kawtar Raghay, Sergio Rodríguez-Cuenca, Rosangela M. Deoliveira, Tamara Castañeda, Rakesh Datta, Jesse Z. Dong, Michael Culler, Mark W. Sleeman, Clara V. Álvarez, Rosalía Gallego, Christopher J. Lelliott, David Carling, Matthias H. Tschöp, Carlos Diéguez, Antonio Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metabolism. ,vol. 7, pp. 389- 399 ,(2008) , 10.1016/J.CMET.2008.03.006
Gianfranco Guarnieri, Michela Zanetti, Pierandrea Vinci, Maria Rosa Cattin, Rocco Barazzoni, Insulin Resistance in Chronic Uremia Journal of Renal Nutrition. ,vol. 19, pp. 20- 24 ,(2009) , 10.1053/J.JRN.2008.11.014